Related Experiment Video
Updated: Sep 27, 2026

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture
Published on: October 24, 2025
Endocrine and Molecular Mechanisms of Oocyte Aging: From Gonadotropin Signaling to Metabolic and Microenvironmental
Maria Fotara1, Efthalia Moustakli2, Maria Anastasia Daskalaki1
1First Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Abstract:
Ovarian aging and oocyte aging are closely interconnected but distinct components of reproductive aging. Whereas ovarian aging encompasses progressive follicular depletion and changes in ovarian endocrine and somatic-cell function, oocyte aging refers more specifically to the age-associated deterioration in the molecular, cellular, and developmental competence of the oocyte. This deterioration contributes to increased aneuploidy, impaired embryonic development, implantation failure, and early pregnancy loss. This narrative review synthesizes current evidence on the endocrine, cellular, and molecular mechanisms underlying oocyte aging and their potential interactions, and examines emerging strategies for preserving oocyte competence. Age-related dysregulation of the hypothalamic-pituitary-ovarian axis, altered gonadotropin signaling, and changes in intraovarian endocrine and paracrine communication may disrupt follicular development and the follicular microenvironment. These changes may compromise functional interactions between the oocyte and surrounding somatic cells. These alterations may converge with mitochondrial dysfunction, oxidative stress, mtDNA abnormalities, impaired energy metabolism, alterations in telomere biology, and epigenetic dysregulation, ultimately compromising oocyte meiotic competence and developmental potential. Experimental strategies, including antioxidant supplementation, restoration of NAD+ metabolism, mitochondrial transfer, and exosome-based interventions, have shown potential to ameliorate features of oocyte aging, primarily in animal and preclinical models. However, none of these interventions has been shown to delay physiological oocyte aging in women, and evidence supporting their clinical effectiveness and long-term safety remains insufficient. Understanding how endocrine dysregulation interacts with metabolic, genomic, and epigenetic alterations and changes in the follicular microenvironment may facilitate the identification of biomarkers and the development of targeted approaches to preserve oocyte quality during reproductive aging.
More Related Videos
09:04Probing the Ovarian Microenvironment: Methods for Isolation, 2D Culture, and Organoid Culture of Mouse Ovarian Somatic Cells
Published on: July 3, 2026
06:49Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice
Published on: February 12, 2018
Related Concept Videos
Oogenesis
Oogenesis
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.